Febustat 40 Tablet contains Febuxostat 40mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat is a xanthine oxidase inhibitor that works by reducing the production of uric acid in the body, thereby preventing the formation of urate crystals that cause painful gout attacks and joint inflammation. This medication is typically prescribed for individuals who have not responded well to other urate-lowering therapies or who have contraindications to allopurinol. Febustat 40 is taken orally, usually once daily, and dosage may be adjusted based on the patient's serum uric acid levels and clinical response. It is important to use this medication under medical supervision, as it may cause side effects such as liver function abnormalities, nausea, rash, and joint pain. Patients with a history of cardiovascular disease should inform their healthcare provider before starting Febustat, as some studies suggest a potential risk of cardiovascular events. Regular monitoring of liver enzymes and kidney function is recommended during treatment. Febustat 40 Tablet offers an effective option for long-term management of gout by maintaining lower uric acid levels and reducing the frequency of gout flares, thereby improving patients' quality of life.